Consistent with prior reports indicating the oncogenic role of TIMP1 in various cancers [27,28,29], our bioinformatic and clinical analyses confirmed that TIMP1 is overexpressed in CRC tissues and patient sera, and its elevated expression is independently associated with poor overall survival. Here, TIMP1 is linked to cancer.